Srpski arhiv za celokupno lekarstvo 2023 Volume 151, Issue 1-2, Pages: 98-105
https://doi.org/10.2298/SARH220830010D
Full text ( 1253 KB)
Cited by
Basal cell carcinoma - principles of treatment
Dimitrijević Milovan V. (University of Belgrade, Faculty of Medicine, Belgrade, Serbia + University Clinical Center of Serbia, Clinic for Otorhinolaryngology and Maxillofacial Surgery, Belgrade, Serbia)
Brašanac Dimitrije Č. (University of Belgrade, Faculty of Medicine, Institute of Pathology, Belgrade, Serbia)
Todorović Nikola R. (University Clinical Center of Serbia, Clinic for Otorhinolaryngology and Maxillofacial Surgery, Belgrade, Serbia)
Petrović Maša G. (University of Belgrade, Faculty of Medicine, Belgrade, Serbia), 5rovicmasa@gmail.com
Dimitrijević Ana M. (University of Belgrade, Faculty of Medicine, Belgrade, Serbia + University Clinical Center of Serbia, Clinic for Eye Diseases, Belgrade, Serbia)
Basal cell carcinoma (BCC) is one of the most common malignant tumors in human medicine and the most common skin malignancy, with the largest number of lesions found on exposed parts of the skin, on the face, head, and neck. The average age of the patients is 60 years, with an increasing incidence in younger ages and an increased incidence in males. The incidence of BCC is increasing and doubles every 25 years. Annually, there are approximately 1,000,000 newly diagnosed cases worldwide. The frequency of malignant skin tumors depends on the influence of external factors such as ultraviolet radiation and other biological properties of the skin with a higher incidence in fair-skinned people (Fitzpatrick type I and type II skin types). BCC is a slow-growing malignant tumor that arises from the basal layer of the epidermis, the outer layer of hair follicles, or the sebaceous glands. BCC can be locally invasive and, if neglected, can infiltrate surrounding structures (muscles and cartilage) and vital structures, which can ultimately lead to death. The clinical presentation is very diverse and dependent on the histological subtype. Prevention is the most important and effective approach towards reducing the burden of BCC. The best treatment for BCC is surgical excision with confirmation and verification of surgical margins. The therapeutic goal is oncologic radical resection of the tumor, followed by reconstruction of the affected area for structure and optimal aesthetic result.
Keywords: carcinoma, basal cell, therapeutics, prognostic factors
Project of the Serbian Ministry of Education, Science and Technological Development, Grant no. 200110
Show references
Dimitrijević MV. Epitelni maligni tumori kože. In: Dimitrijevic MV, et al. Maksilofacijalna hirurgija. Beograd: Medicinski fakultet; 2020. p. 165-70.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. [DOI: 10.3322/caac.21660] [PMID: 33538338]
Institute of Public Health of Serbia “Dr Milan Jovanović Batut”. Department for Prevention and Control of Noncommunicable Diseases. Malignant Tumors in Republic of Serbia 2018. Serbian cancer registry, Beograd, 2020.
Trakatelli M, Morton C, Nagore E, Ulrich C, Del Marmol V, Peris K, et al; BCC subcommittee of the Guidelines Committee of the European Dermatology Forum. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol. 2014;24(3):312-29. [DOI: 10.1684/ejd.2014.2271] [PMID: 24723647]
Telfer NR, Colver GB, Morton CA; British Association of Dermatologists. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 2008;159(1):35-48. [DOI: 10.1111/j.1365-2133.2008.08666.x] [PMID: 18593385]
Migden MR, Chen L, Silapunt S, editors. Basal Cell Carcinoma: Advances in Treatment and Research. First Edition. Springer Nature Switzerland AG; 2020. p. 290. [DOI: 10.1007/978-3-030-26887-9]
Videnović G, Miljuš D, Ilić D, Krasić D, Živković S. Nonmelanoma Skin Cancer in the Population of the City of Belgrade in the Period 1999-2011. Srp Arh Celok Lek. 2015;143(5-6):290-5. [DOI: 10.2298/sarh1506290v] [PMID: 26259401]
Green A, Battistutta D. Incidence and determinants of skin cancer in a high-risk Australian population. Int J Cancer. 1990;46(3):356- 61. [DOI: 10.1002/ijc.2910460303] [PMID: 2394501]
Dimitrijević M, Jović M, Stojkovic G, Dimitrijevic A. Reconstruction of the large columella defect with Schmid-Meyer flap. Vojnosanitet Pregl. 2022;79(12);1274-76. [DOI: 10.2298/VSP210223091D]
Reinau D, Surber C, Jick SS, Meier CR. Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors, and comorbidities. Br J Cancer. 2014;111(1):203-6. [DOI: 10.1038/bjc.2014.265] [PMID: 24874476]
Wu S, Han J, Li WQ, Li T, Qureshi AA. Basal-cell carcinoma incidence and associated risk factors in U.S. women and men. Am J Epidemiol. 2013;178(6):890-7. [DOI: 10.1093/aje/kwt073] [PMID: 23828250]
Jesić S, Radulović R, Djerić D, Nesić V, Dimitrijević M, Petrović Z, et al. Karcinom koze spoljasnjeg slusnog hodnika [Carcinoma of the skin of the external auditory meatus]. Acta Chir Iugosl. 2004;51(1):55-9. Serbian. [DOI: 10.2298/aci0401055j] [PMID: 15756788]
Dimitrijević M, Vujičić Z, Trivić A. Surgical treatment of advanced malignant tumors of the skin in head and neck region; 2nd Balkan Congress for Plastic, Reconstructive and Aesthetic Surgery and ISAPS-Mini Course. Belgrade, Yugoslavia; 2001. p. 105.
Muzic JG, Schmitt AR, Wright AC, Alniemi DT, Zubair AS, Olazagasti Lourido JM, et al. Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma: A Population-Based Study in Olmsted County, Minnesota, 2000 to 2010. Mayo Clin Proc. 2017;92(6):890-8. [DOI: 10.1016/j.mayocp.2017.02.015] [PMID: 28522111]
Ferrucci LM, Cartmel B, Molinaro AM, Leffell DJ, Bale AE, Mayne ST. Indoor tanning and risk of early-onset basal cell carcinoma. J Am Acad Dermatol. 2012;67(4):552-62. [DOI: 10.1016/j.jaad.2011.11.940] [PMID: 22153793]
Housman TS, Williford PM, Feldman SR, Teuschler HV, Fleischer AB Jr, Goldman ND, et al. Nonmelanoma skin cancer: an episode of care management approach. Dermatol Surg. 2003;29(7):700-11. [DOI: 10.1046/j.1524-4725.2003.29185.x] [PMID: 12828693]
Jović MS, Dimitrijević MM, Dimitrijević AM, Stojković GG. Analysis of reconstructive methods in surgical treatment of nasal skin defects. Vojnosanit Pregl. 2016;73(8):723-7. [DOI: 10.2298/VSP140829052J] [PMID: 29328583]
Walker P, Hill D. Surgical treatment of basal cell carcinomas using standard postoperative histological assessment. Australas J Dermatol. 2006;47(1):1-12. [DOI: 10.1111/j.1440-0960.2006.00216.x] [PMID: 16405477]
Griffiths RW, Suvarna SK, Stone J. Do basal cell carcinomas recur after complete conventional surgical excision? Br J Plast Surg. 2005;58(6):795-805. [DOI: 10.1016/j.bjps.2005.02.010] [PMID: 16086990]
Wilson AW, Howsam G, Santhanam V, Macpherson D, Grant J, Pratt CA, et al. Surgical management of incompletely excised basal cell carcinomas of the head and neck. Br J Oral Maxillofac Surg. 2004;42(4):311-4. [DOI: 10.1016/j.bjoms.2004.02.030] [PMID: 15225948]
Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol. 1990;23(6 Pt 1):1118-26. [DOI: 10.1016/0190-9622(90)70344-h] [PMID: 2273112]
Hauschild A, Breuninger H, Kaufmann R, Kortmann RD, Schwipper V, Werner J, et al. Short German guidelines: basal cell carcinoma. J Dtsch Dermatol Ges. 2008;6 Suppl 1:S2-4. [Article in English, German] [DOI: 10.1111/j.1610-0387.2008.06708.x] [PMID: 18801139]
Zloty D, Guenther LC, Sapijaszko M, Barber K, Claveau J, Adamek T, et al; Canadian Non-melanoma Skin Cancer Guidelines Committee. Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma. J Cutan Med Surg. 2015;19(3):239-48. [DOI: 10.1177/1203475415586664] Erratum in: J Cutan Med Surg. 2015;19(6):604. [PMID: 25986316]
Schierbeck J, Vestergaard T, Bygum A. Skin Cancer Associated Genodermatoses: A Literature Review. Acta Derm Venereol. 2019;99(4):360-9. [DOI: 10.2340/00015555-3123] [PMID: 30653245]
Cameron MC, Lee E, Hibler BP, Giordano CN, Barker CA, Mori S, et al. Basal cell carcinoma: Contemporary approaches to diagnosis, treatment, and prevention. J Am Acad Dermatol. 2019;80(2):321- 39. [DOI: 10.1016/j.jaad.2018.02.083] Erratum in: J Am Acad Dermatol. 2019;81(1):310. [PMID: 29782901]
Pellegrini C, Maturo MG, Di Nardo L, Ciciarelli V, Gutierrez Garcia- Rodrigo C, Fargnoli MC. Understanding the Molecular Genetics of Basal Cell Carcinoma. Int J Mol Sci. 2017;18(11):2485. [DOI: 10.3390/ijms18112485] [PMID: 29165358]
Elder DE, Massi D, Scolyer RA, Willemze R, editors. WHO classification of skin tumours. International Agency for Research on Cancer; 2018.
Kuonen F, Huskey NE, Shankar G, Jaju P, Whitson RJ, Rieger KE, et al. Loss of Primary Cilia Drives Switching from Hedgehog to Ras/MAPK Pathway in Resistant Basal Cell Carcinoma. J Invest Dermatol. 2019;139(7):1439-48. [DOI: 10.1016/j.jid.2018.11.035] [PMID: 30707899]
De Giorgi V, Savarese I, Gori A, Scarfi F, Topa A, Trane L, et al. Advanced basal cell carcinoma: when a good drug is not enough. J Dermatolog Treat. 2020;31(6):552-3. [DOI: 10.1080/09546634.2018.1542481] [PMID: 30388924]
Kamath P, Darwin E, Arora H, Nouri K. A Review on Imiquimod Therapy and Discussion on Optimal Management of Basal Cell Carcinomas. Clin Drug Investig. 2018;38(10):883-99. [DOI: 10.1007/s40261-018-0681-x] [PMID: 30128748]
Martens MC, Seebode C, Lehmann J, Emmert S. Photocarcinogenesis and Skin Cancer Prevention Strategies: An Update. Anticancer Res. 2018;38(2):1153-8. [DOI: 10.21873/anticanres.12334] [PMID: 29374752]
Skoda AM, Simovic D, Karin V, Kardum V, Vranic S, Serman L. The role of the Hedgehog signaling pathway in cancer: A comprehensive review. Bosn J Basic Med Sci. 2018;18(1):8-20. [DOI: 10.17305/bjbms.2018.2756] [PMID: 29274272]
Weber P, Tschandl P, Sinz C, Kittler H. Dermatoscopy of Neoplastic Skin Lesions: Recent Advances, Updates, and Revisions. Curr Treat Options Oncol. 2018;19(11):56. [DOI: 10.1007/s11864-018-0573-6] [PMID: 30238167]
Brasanac D, Boricic I, Todorovic V, Tomanovic N. Primary cutaneous carcinosarcoma: case report with expanded immunohistochemical analysis. Int J Dermatol. 2008;47(5):496- 501. [DOI: 10.1111/j.1365-4632.2008.03427.x] [PMID: 18412870]
Moyer VA; U.S. Preventive Services Task Force. Behavioral counseling to prevent skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(1):59-65. [DOI: 10.7326/0003-4819-157-1-201207030-00442] [PMID: 22751761]
Sanchez G, Nova J, Rodriguez-Hernandez AE, Medina RD, Solorzano-Restrepo C, Gonzalez J, et al. Sun protection for preventing basal cell and squamous cell skin cancers. Cochrane Database Syst Rev. 2016;7(7):CD011161. [DOI: 10.1002/14651858.CD011161.pub2] [PMID: 27455163]
Slater MC, Cook M. Dataset for histopathological reporting of primary cutaneous malignant melanoma and regional lymph nodes. Standards and datasets for reporting cancers. London: The Royal College of Pathologists; 2019. p. 49.
Popadić M, Brasanac D. The use of dermoscopy in distinguishing the histopathological subtypes of basal cell carcinoma: A retrospective, morphological study. Indian J Dermatol Venereol Leprol. 2022;88(5):598-607. [DOI: 10.25259/IJDVL_1276_20] [PMID: 35146979]
Brantsch KD, Meisner C, Schonfisch B, Trilling B, Wehner-Caroli J, Rocken M, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713-20. [DOI: 10.1016/S1470-2045(08)70178-5] [PMID: 18617440]
Sun H, Jiang P. MicroRNA-451a acts as tumor suppressor in cutaneous basal cell carcinoma. Mol Genet Genomic Med. 2018;6(6):1001-9. [DOI: 10.1002/mgg3.473] [PMID: 30209892]
Hughley BB, Schmalbach CE. Cutaneous Head and Neck Malignancies in the Elderly. Clin Geriatr Med. 2018;34(2):245-58. [DOI: 10.1016/j.cger.2018.01.004] [PMID: 29661336]
Dika E, Scarfi F, Ferracin M, Broseghini E, Marcelli E, Bortolani B, et al. Basal Cell Carcinoma: A Comprehensive Review. Int J Mol Sci. 2020;21(15):5572. [DOI: 10.3390/ijms21155572] [PMID: 32759706]
Al Wohaib M, Al Ahmadi R, Al Essa D, Maktabbi A, Khandekar R, Al Sharif E, et al. Characteristics and Factors Related to Eyelid Basal Cell Carcinoma in Saudi Arabia. Middle East Afr J Ophthalmol. 2018;25(2):96-102. [DOI: 10.4103/meajo.MEAJO_305_17] [PMID: 30122855]
Petrovic M, Shamsian A, Hopp ML, Vardanyan N. Evaluating the Efficacy and Trend of Sinus Surgery. Int Arch Otorhinolaryngol. 2020;24(4):e407-e412. [DOI: 10.1055/s-0039-3402436] [PMID: 33101503]